The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(4-(Furan-3-yl)-1H-imidazol-1-yl)-3-isopropyl-1H-pyrazolo-[3,4-b]pyridin-1-yl)-2-((trans-4-hydroxycyclohexyl)amino)-benzamide ID: ALA4513271
PubChem CID: 67500027
Max Phase: Preclinical
Molecular Formula: C29H31N7O3
Molecular Weight: 525.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)c1nn(-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)c2nccc(-n3cnc(-c4ccoc4)c3)c12
Standard InChI: InChI=1S/C29H31N7O3/c1-17(2)27-26-25(35-14-24(32-16-35)18-10-12-39-15-18)9-11-31-29(26)36(34-27)20-5-8-22(28(30)38)23(13-20)33-19-3-6-21(37)7-4-19/h5,8-17,19,21,33,37H,3-4,6-7H2,1-2H3,(H2,30,38)/t19-,21-
Standard InChI Key: LVORWQJQVXJYNE-XUTJKUGGSA-N
Molfile:
RDKit 2D
39 44 0 0 0 0 0 0 0 0999 V2000
4.5262 -6.0340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5250 -6.8535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2331 -7.2625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2313 -5.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2260 -4.8108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9399 -6.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9447 -6.8490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7247 -7.0974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2021 -6.4323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7170 -5.7729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9804 -7.8686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4354 -8.4790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6919 -9.2541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4930 -9.4199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0371 -8.8046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7777 -8.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7511 -10.1953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2086 -10.8065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5516 -10.3595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8380 -8.9670 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3791 -8.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1789 -8.5211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7191 -7.9127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4632 -7.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6618 -6.9717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1162 -7.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0066 -6.5259 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9649 -4.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7632 -4.8197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6321 -4.4337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8792 -4.3262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6226 -3.5534 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8082 -3.5586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5617 -4.3348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3273 -2.9015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5812 -2.1253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9208 -1.6489 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2636 -2.1298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5180 -2.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
4 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
8 11 1 0
14 17 1 0
17 18 1 0
17 19 2 0
15 20 1 0
21 20 1 6
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
24 27 1 1
10 28 1 0
28 29 1 0
28 30 1 0
5 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 5 1 0
33 35 1 0
35 36 2 0
36 37 1 0
37 38 1 0
38 39 2 0
39 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 525.61Molecular Weight (Monoisotopic): 525.2488AlogP: 4.80#Rotatable Bonds: 7Polar Surface Area: 137.02Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.91CX LogP: 3.93CX LogD: 3.92Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.28Np Likeness Score: -0.90
References 1. Uno T, Kawai Y, Yamashita S, Oshiumi H, Yoshimura C, Mizutani T, Suzuki T, Chong KT, Shigeno K, Ohkubo M, Kodama Y, Muraoka H, Funabashi K, Takahashi K, Ohkubo S, Kitade M.. (2019) Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor., 62 (2): [PMID:30525599 ] [10.1021/acs.jmedchem.8b01085 ]